Malnutrition prevalence in cancer patients in Belgium: The ONCOCARE study

Marika Rasschaert,Pieter Vandecandelaere,Stéphanie Marechal,Randal D’hondt,Christof Vulsteke,Marie Mailleux,Wendy De Roock,Joanna Van Erps,Ulrike Himpe,Marc De Man,Geertrui Mertens,Dirk Ysebaert

DOI: https://doi.org/10.1007/s00520-024-08324-6

IF: 3.1

2024-01-29

Supportive Care in Cancer

Abstract:Unintentional weight loss and malnutrition are common among cancer patients. Malnutrition has been associated with impaired health-related quality of life, less well-tolerated chemotherapy regimens and shorter life duration. In Belgium there is a lack of epidemiological data on malnutrition in oncology patients at advanced stages of the disease.

oncology,health care sciences & services,rehabilitation

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper aims to address the prevalence and assessment issues of malnutrition among cancer patients in Belgium. Specifically, the main objectives of the study include:

1. **Assessing the Risk of Malnutrition**: Prospectively assess the risk of malnutrition in cancer patients who require neoadjuvant anticancer therapy or have been diagnosed with metastatic cancer and are starting first-line, second-line, or third-line palliative anticancer treatment using the NRS 2002 scoring tool.

2. **Evaluating Malnutrition Diagnosis**: Assess the diagnosis of malnutrition according to the GLIM criteria (Global Leadership Initiative on Malnutrition) and physician subjective assessment (PSA).

3. **Estimating the Prevalence of Sarcopenia and Cachexia**: Estimate the prevalence of sarcopenia and cachexia among the study subjects.

4. **Evaluating Clinical Practice and Outcomes**: Evaluate the effectiveness of nutritional support measures in actual clinical practice and monitor the clinical outcomes of patients receiving anticancer treatment.

### Main Findings

1. **High Risk of Malnutrition**: At baseline (BV), 54.5% of patients were at risk of malnutrition (NRS 2002 score ≥3), and this proportion further increased to 73.2% (FUV1) and 70.1% (FUV2) during subsequent follow-ups.

2. **Physicians Underestimated Malnutrition**: The prevalence of malnutrition assessed by physicians' subjective assessment was significantly lower than the results from NRS 2002 and GLIM criteria, indicating that physicians failed to adequately identify malnutrition in actual clinical practice.

3. **Insufficient Nutritional Interventions**: Only 10% of patients received a nutritional plan at baseline, and nutritional intake significantly decreased during the follow-up period.

4. **Sarcopenia and Cachexia**: The prevalence of sarcopenia and cachexia was 12.4% and 38.1%, respectively, but physicians' subjective assessments significantly underestimated these conditions.

### Conclusion

The study confirms that malnutrition is prevalent and underestimated among cancer patients in Belgium. Early identification and intervention of malnutrition are crucial for improving patient outcomes. Additionally, patients' daily dietary records provide additional information that helps in the early detection of malnutrition and sarcopenia.